Synthesis and Biological Evaluation of Novel 5-Benzylidenethiazolidine-2,4-dione Derivatives for the Treatment of Inflammatory Diseases-Reference-Cited by-同舟云学术

Synthesis and Biological Evaluation of Novel 5-Benzylidenethiazolidine-2,4-dione Derivatives for the Treatment of Inflammatory Diseases

Published:2011-03-07 Issue:7 Volume:54 Page:2060-2068
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ma Liang¹,Xie Caifeng¹,Ma Yinghua¹,Liu Juan¹,Xiang Mingli¹,Ye Xia¹,Zheng Hao¹,Chen Zhizhi¹,Xu Qinyuan¹,Chen Tao¹,Chen Jinying¹,Yang Jincheng¹,Qiu Neng¹,Wang Guangcheng¹,Liang Xiaolin¹,Peng Aihua¹,Yang Shengyong¹,Wei Yuquan¹,Chen Lijuan¹

Affiliation:

1. State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm1011534

Reference31 articles.

1. Inflammation 2010: New Adventures of an Old Flame

2. Origin and physiological roles of inflammation

3. Points of control in inflammation

4. NITRIC OXIDE AND MACROPHAGE FUNCTION

5. Nitric Oxide and Inflammation

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An efficient green synthesis and in vitro evaluation of novel adamantane-containing 4-thiazolidinone derivatives as anticancer agents;Journal of Molecular Structure;2025-02

2. SKLB023 protects against inflammation and apoptosis in sepsis-associated acute kidney injury via the inhibition of toll-like receptor 4 signaling;International Immunopharmacology;2024-09

3. Thiazolidines derivatives and their anti-inflammatory activity in LPS-induced RAW 264.7 macrophages: a systematic review and meta-analysis;Natural Product Research;2024-08-21

4. Prospective de novo drug design with deep interactome learning;Nature Communications;2024-04-22

5. New 2-oxoindole derivatives as multiple PDGFRα/ß and VEGFR-2 tyrosine kinase inhibitors;Bioorganic Chemistry;2024-04